Concentration Distribution of Anti-VEGF Drugs Injected Into the Vitreous Cavity of Vitrectomy and Non-vitrectomy Eyes
Abstract Objective: To study the difference of retinal drug concentration distribution of anti-VEGF drugs injected into the vitreous cavity of vitrectomy and non-vitrectomy eyes.Methods: This article reviews the related studies on the distribution of retinal drugs after vitrectomy and non-vitrectomy eyes after IVI of anti-VEGF drugs. Results: There were few studies on retinal drug concentration after vitrectomy and non-vitrectomy eyes after vitreous injection of anti-VEGF drugs. Pharmacokinetics plays an important role in drug tissue distribution and onset time. A faster drug clearance rate can theoretically explain that the shorter retention time of anti-VEGF drugs in the vitreous cavity after intraocular injection of anti-VEGF drugs after vitrectomy, the lower concentration of anti-VEGF drugs in the vitreous cavity at the same time point, which can explain the reason for the poor efficacy of anti-VEGF treatment in the eyes after vitrectomy. Therefore, we have reason to believe that there is a difference in retinal drug concentration after vitrectomy and non-vitrectomy eyes after intravitreous injection of anti-VEGF drugs. Previous research results may have some deficiencies, which need to be verified by further research. Conclusion: There are differences in retinal drug concentration between vitrectomy eyes and non-vitrectomy eyes after vitreous injection of anti-VEGF drugs. There may be some deficiencies in the previous research results, which need to be verified by further research.